Keyphrases
Acquired Resistance
100%
Aggressive Phenotype
22%
Breast Cancer Cells
100%
Breast Cancer Patients
22%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
Clinical Outcomes
11%
Coated Membrane
11%
Cooperative Effects
11%
ErbB2
33%
ERK2
22%
Expression Level
11%
High Ability
11%
Induced Cell Death
11%
Invasive Ability
11%
Invasiveness
100%
Kinase Activity
11%
Lapatinib
100%
Matrigel
11%
Overexpressing
22%
Phosphorylation
11%
Resistance Mechanisms
11%
Resistant Breast Cancer
11%
Resistant Cells
33%
Saracatinib
22%
Src Inhibition
11%
Src Inhibitor
11%
Src Kinase
11%
Src Signaling
22%
Subclone
11%
Therapeutic Intervention
22%
Tyrosine Kinase Inhibitor
11%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cell Death
11%
CXCR4
100%
Epidermal Growth Factor Receptor
11%
ErbB
33%
Kinase
11%
Lapatinib
100%
Phosphotransferase
11%
Protein Kinase B
22%
TRAIL
11%
Tyrosine Kinase Inhibitor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Epidermal Growth Factor Receptor
11%
Lapatinib
100%
Matrigel
11%
Mitogen Activated Protein Kinase 3
22%
Phosphotransferase
11%
Protein Kinase B
22%
Protein Tyrosine Kinase Inhibitor
11%
Saracatinib
22%